Drugs / Aneustat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01555242 | Aug 2012 → Jan 2014 | neoplasm | Omnitura Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aneustat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01555242 ↗ |
| Known as | OMN54 | “Aneustat (OMN54)” NCT01555242 ↗ |
| Route | Oral | “oral administration” NCT01555242 ↗ |